
Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders
Author(s) -
Mi Kwon,
Rebeca Bailén,
Pascual Balsalobre,
Manuel Jurado,
Arancha Bermúdez,
Jon Badiola,
Albert Esquirol,
Pilar Miralles,
Elisa López-Fernández,
Jaime Sanz,
Lucrecia Yáñez,
Mercedes Colorado,
José Luís Piñana,
Nieves Dorado,
Laura Solán,
Carolina Martínez-Laperche,
Ismael Buño,
Javier Anguita,
David Serrano,
José L. Díez-Martín,
Grupo Español de Trasplante Hematopoyético y Terapia Celular
Publication year - 2019
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000002209
Subject(s) - medicine , hematopoietic stem cell transplantation , transplantation , population , disease , immunology , environmental health
Although a number of patients with HIV infection and hematological disease have successfully undergone allogeneic hematopoietic stem-cell transplantation (HSCT), short and long-term outcomes remain not well known. We report the largest Spanish experience treating HIV-infected adult patients with high-risk hematological malignancies with allogeneic HSCT.